MDNA Life Sciences Inc. (MDLS)

MDNA Life Sciences was planning to go public, but the IPO was withdrawn on Feb 21, 2025.

IPO Price Range

$5.00 - $6.00

Shares Offered

2,454,545

Deal Size

$13.50M

MDNA Life Sciences Financials Overview

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep '21 Sep 30, 2021	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Revenue	3.6	3.6	0.11
Revenue Growth	-	3298.10%	-
Gross Profit	1.78	1.78	-0
Operating Income	-1.02	-1.02	-3.19
Net Income	-3.79	-3.79	-5.29

Fiscal Year	Current	FY 2021	FY 2020
Period Ending	Sep '21 Sep 30, 2021	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Cash & Investments	0.96	0.96	0.05
Total Debt	16.69	16.69	14.19
Net Cash (Debt)	-15.73	-15.73	-14.14
Net Cash Growth	-	-	-

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep '21 Sep 30, 2021	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Operating Cash Flow	-0.56	-0.56	-1.38
Capital Expenditures	-0.06	-0.06	-0.25
Free Cash Flow	-0.62	-0.62	-1.63
Free Cash Flow Growth	-	-	-

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep '21 Sep 30, 2021	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Gross Margin	49.49%	49.49%	-0.19%
Operating Margin	-28.29%	-28.29%	-3009.37%
Pretax Margin	-105.14%	-105.14%	-4994.05%
Profit Margin	-105.14%	-105.14%	-4994.05%
FCF Margin	-17.25%	-17.25%	-1536.33%